Pregmune Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $277K

  • Investors
  • 1

Pregmune General Information

Description

Developer of an artificial intelligence-powered reproductive immunology assessment designed to identify immunological causes of infertility, recurrent pregnancy loss, and IVF failure. The company offers an AI-driven diagnostic platform that analyses clinical history and immunological markers using machine learning and reproductive immunology expertise, enabling individuals to gain personalised insights and evidence-based guidance for follow-up care in collaboration with their physicians.

Contact Information

Website
www.pregmune.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 320 Nevada Street
  • Suite 301
  • Newton, MA 02460
  • United States
+1 (800)
Primary Industry
Decision/Risk Analysis
Vertical(s)
Digital Health, SaaS, Artificial Intelligence & Machine Learning, FemTech
Corporate Office
  • 320 Nevada Street
  • Suite 301
  • Newton, MA 02460
  • United States
+1 (800)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Pregmune Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 03-Jan-2024 $277K Completed Generating Revenue
2. Early Stage VC 26-Sep-2022 Completed Generating Revenue
1. Seed Round 18-May-2021 $302K $302K Completed Generating Revenue
To view Pregmune’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Pregmune Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Pregmune Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Feel Venture Venture Capital Minority
To view Pregmune’s complete investors history, request access »

Ready to get started?

Request a free trial

Pregmune FAQs

  • When was Pregmune founded?

    Pregmune was founded in 2020.

  • Where is Pregmune headquartered?

    Pregmune is headquartered in Newton, MA.

  • What is the size of Pregmune?

    Pregmune has 7 total employees.

  • What industry is Pregmune in?

    Pregmune’s primary industry is Decision/Risk Analysis.

  • Is Pregmune a private or public company?

    Pregmune is a Private company.

  • What is Pregmune’s current revenue?

    The current revenue for Pregmune is .

  • How much funding has Pregmune raised over time?

    Pregmune has raised $704K.

  • Who are Pregmune’s investors?

    Feel Venture has invested in Pregmune.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process